![Ramona M. Lloyd](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Profil
Ramona M.
Lloyd is currently Vice President-Regulatory Affairs & Quality at OptiNose, Inc. since 2014.
Former positions include Director-Regulatory Affairs & Quality at Sanofi, Vice President-Regulatory Affairs at Bristol Myers Squibb Co., Senior Vice President-Regulatory Affairs & Safety at ImClone LLC from 2009 to 2010, Vice President-Regulatory Affairs at Johnson & Johnson, and Vice President-Regulatory Affairs at Omthera Pharmaceuticals, Inc. from 2011 to 2012.
Education includes undergraduate studies at the University of Massachusetts and a doctorate from Robert Wood Johnson Medical School.
Aktive Positionen von Ramona M. Lloyd
| Unternehmen | Position | Beginn |
|---|---|---|
| OPTINOSEPAR | General Counsel | 12.06.2014 |
Ehemalige bekannte Positionen von Ramona M. Lloyd
| Unternehmen | Position | Ende |
|---|---|---|
Omthera Pharmaceuticals, Inc.
 Omthera Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as pharmaceuticals company which focuses on the clinical development of new therapies for dyslipidemia | General Counsel | 01.01.2012 |
ImClone LLC
 ImClone LLC BiotechnologyHealth Technology Develops novel therapeutic products and blood cell growth factors for the treatment of cancer | General Counsel | 01.01.2010 |
| SANOFI | General Counsel | - |
| JOHNSON & JOHNSON | General Counsel | - |
| BRISTOL-MYERS SQUIBB COMPANY | General Counsel | - |
Ausbildung von Ramona M. Lloyd
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
47
Beziehungen ersten Grades
8
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 8 |
|---|---|
Bristol Myers Squibb Co.
 Bristol Myers Squibb Co. Pharmaceuticals: MajorHealth Technology Manufactures and markets biopharmaceuticals products | Health Technology |
ImClone LLC
ImClone LLC BiotechnologyHealth Technology Develops novel therapeutic products and blood cell growth factors for the treatment of cancer | Health Technology |
Johnson & Johnson
 Johnson & Johnson Pharmaceuticals: MajorHealth Technology Operates as an investment holding company with interests in health care products | Health Technology |
Sanofi
 Sanofi Pharmaceuticals: MajorHealth Technology Engages in research, development and production of pharmaceuticals & vaccines | Health Technology |
Omthera Pharmaceuticals, Inc.
Omthera Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as pharmaceuticals company which focuses on the clinical development of new therapies for dyslipidemia | Health Technology |
OptiNose, Inc.
 OptiNose, Inc. Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company that develops and commercializes products for patients treated by ear, nose, throat and allergy diseases | Health Technology |
University of Massachusetts
 University of Massachusetts Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Robert Wood Johnson Medical School
 Robert Wood Johnson Medical School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
